FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ADALIMUMAB-AATY, a biosimilar adalimumab from Celltrion USA, Inc., in connection with its regulatory status as a Hum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Hidradenitis Suppurativa
• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB-AATY (adalimumab)

Snippet

SUPPL AP for ADALIMUMAB (ADALIMUMAB-AATY)